The utility of intraoperative PTH dosage in primary hyperparathyroidism based on preoperative diagnosis and surgical choice

Minerva Surg. 2023 Feb;78(1):1-10. doi: 10.23736/S2724-5691.22.09474-6. Epub 2022 Mar 25.

Abstract

Background: The aim of this study was to evaluate the impact of the intraoperative PTH (ioPTH) monitoring in the success of parathyroidectomy based on the concordant or indeterminate preoperative imaging studies of localization and the performed surgical choices.

Methods: Fourthy-seven patients who received parathyroidectomy operations were divided in four groups: concordance of the imaging and ioPTH, concordance of the imaging and no ioPTH, indeterminate imaging and ioPTH and indeterminate imaging and no ioPTH.

Results: Overall, patients in whom ioPTH monitoring was not performed were healed in 89.47% of cases, while the percentage of recovery in patients receiving ioPTH was 85.71%. There were no differences in the changes in strategy or in the cure rates with the use of ioPTH.

Conclusions: No significant differences were found, independently from the preoperative imaging agreement, in either the cure rate or in the change of intraoperative strategy using the ioPTH dosage.

MeSH terms

  • Humans
  • Hyperparathyroidism, Primary* / surgery
  • Intraoperative Care
  • Monitoring, Intraoperative / methods
  • Parathyroid Hormone
  • Parathyroidectomy / methods
  • Retrospective Studies

Substances

  • Parathyroid Hormone